Offer - Urjas Oil for just ₹ 1
Wosulin 50/50 Solution for Injection 100 IU/ml is a prescription medicine that is available as a Injection. Primarily, it is used for the treatment of Diabetes Type 1, Diabetes Type 1. Secondary and off-label uses of Wosulin 50/50 Solution for Injection 100 IU/ml have also been mentioned below.
The correct dosage of Wosulin 50/50 Solution for Injection 100 IU/ml depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Wosulin 50/50 Solution for Injection 100 IU/ml as well, which are listed below. Normally, these side effects of Wosulin 50/50 Solution for Injection 100 IU/ml are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Wosulin 50/50 Solution for Injection 100 IU/ml's effect is Safe during pregnancy and Unknown for lactating mothers. In addition, Wosulin 50/50 Solution for Injection 100 IU/ml's effects on the liver, heart and kidney are discussed below in the Wosulin 50/50 Solution for Injection 100 IU/ml related warnings section.
Some other conditions that can be affected by Wosulin 50/50 Solution for Injection 100 IU/ml are listed in the contraindications section below.
Besides this, Wosulin 50/50 Solution for Injection 100 IU/ml may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Wosulin 50/50 Solution for Injection 100 IU/ml is considered safe while driving, and is addictive.
Wosulin 50/50 Solution for Injection 100 IU/ml is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Wosulin 50/50 Solution for Injection 100 IU/ml safe for pregnant women?
Wosulin is safe for pregnant women.
Is the use of Wosulin 50/50 Solution for Injection 100 IU/ml safe during breastfeeding?
Information about safety of Wosulin for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Wosulin 50/50 Solution for Injection 100 IU/ml on the Kidneys?
Wosulin may have mild side effects on the kidneys.
What is the effect of Wosulin 50/50 Solution for Injection 100 IU/ml on the Liver?
Very few cases of side effects of Wosulin on the liver have been reported.
What is the effect of Wosulin 50/50 Solution for Injection 100 IU/ml on the Heart?
Very few cases of side effects of Wosulin on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Wosulin 50/50 Solution for Injection 100 IU/ml unless your doctor advises you to do so -
Is this Wosulin 50/50 Solution for Injection 100 IU/ml habit forming or addictive?
No, you will not get addicted to Wosulin 50/50 Solution for Injection 100 IU/ml.
Interaction between Food and Wosulin 50/50 Solution for Injection 100 IU/ml
There is no information on the effects of taking Wosulin 50/50 Solution for Injection 100 IU/ml with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Wosulin 50/50 Solution for Injection 100 IU/ml
Drinking alcohol while taking Wosulin 50/50 Solution for Injection 100 IU/ml may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Novolin® N (Human Insulin Isophane)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Humulin® N (Human Insulin Isophane)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 693-695
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Humulin® R (regular insulin human)
